Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Announcement & Circular
Stock Information
02186.HK
0 0  (0%)
Volume：0
03-17
2026
NOTICE OF BOARD MEETING
Publisher：
03-05
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Publisher：
02-05
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Publisher：
01-27
2026
DISCLOSEABLE AND CONNECTED TRANSACTION CAPITAL INJECTION IN NANJING LUYE
Publisher：
01-27
2026
DISCLOSEABLE TRANSACTIONS AND CONNECTED TRANSACTION FURTHER ANNOUNCEMENT ON THE TRANSFER OF 25% INTEREST IN NANJING LUYE AND RELATED TRANSACTIONS - COMPLETION OF THE EQUITY ...
Publisher：
01-08
2026
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR CLASS 1 INNOVATIVE DRUG RUOXINLIN FOR THE NEW INDICATION OF GENERALIZED ANXIETY DISORDER ACCEPTED IN CHINA
Publisher：
01-06
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Publisher：
12-31
2025
Terms of Reference for Nomination Committee of the board of directors of the Company
Publisher：
12-31
2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
12-31
2025
APPOINTMENT OF NOMINATION COMMITTEE MEMBER
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Stock Information
02186.HK
Volume：0
0
0  (0%)
Announcement & Circular
03-17
2026
NOTICE OF BOARD MEETING
03-05
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
02-05
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
01-27
2026
DISCLOSEABLE AND CONNECTED TRANSACTION CAPITAL INJECTION IN NANJING LUYE
01-27
2026
DISCLOSEABLE TRANSACTIONS AND CONNECTED TRANSACTION FURTHER ANNOUNCEMENT ON THE TRANSFER OF 25% INTEREST IN NANJING LUYE AND RELATED TRANSACTIONS - COMPLETION OF THE EQUITY TRANSFER
01-08
2026
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR CLASS 1 INNOVATIVE DRUG RUOXINLIN FOR THE NEW INDICATION OF GENERALIZED ANXIETY DISORDER ACCEPTED IN CHINA
01-06
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
12-31
2025
Terms of Reference for Nomination Committee of the board of directors of the Company
12-31
2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
12-31
2025
APPOINTMENT OF NOMINATION COMMITTEE MEMBER
First
1
2
3
4
5
Last